Assessment of antibiotic pharmacokinetics, molecular biomarkers and clinical status in critically ill adults diagnosed with community-acquired pneumonia
Published: 8 June 2022| Version 2 | DOI: 10.17632/w7gt8zdp3r.2
Contributor:
István VinczeDescription
The protocol of a clinical study aimed at the characterization of the pharmacokinetics of piperacillin and tazobactam and its association with the concentrations of inflammatory markers and adrenal steroids during CAP therapy will be investigated in up to 40 critically ill patients.
Files
Institutions
Semmelweis Egyetem
Categories
Observational Study